Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases
Background. In Mexico, asthma is one of the top twenty causes of disease with 254,713 new cases reported in 2019. According to Phase 3 of the International Study of Asthma and Allergies in Childhood, the prevalence of asthma ranged from 5 to 14% in 6 Mexican cities with varied geographic conditions...
| Үндсэн зохиолчид: | , , , , , , , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2024-04-01
|
| Цуврал: | Revista Alergia México |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://revistaalergia.mx/ojs/index.php/ram/article/view/1279 |